PFND Stock: Pathfinder Cell Therapy, Inc. Stock Price, Analysis & Insights
Get live PFND stock price $0.00, comprehensive Pathfinder Cell Therapy, Inc. stock analysis, charts, news, and expert forecast. Real-time PFND stock data and investment insights.
Loading chart data...
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Pathfinder Cell Therapy, Inc. is an emerging biotechnology firm specializing in regenerative medicine. This company is dedicated to pioneering innovative cell-based and associated treatments designed to address a range of illnesses and health issues,...
Company Information
- CEO
- Richard L. Franklin
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 1
Contact Information
- Address
- 12 Bow Street
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Lower volatility stock (Beta: -24.33) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Pathfinder Cell Therapy, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Pathfinder Cell Therapy, Inc.
- ⚠Investors should consider how Pathfinder Cell Therapy, Inc. fits within their overall portfolio allocation
Market Cap
66.72K
Beta
-24.33
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare PFND with peer companies:
- Price
- $0.00
- Market cap
- 997.50K
- Price
- $0.00
- Market cap
- 5.25K
- Price
- $0.25
- Market cap
- 105.22K
- Price
- $0.00
- Market cap
- 47.14K
- Price
- $0.00
- Market cap
- 155.50K
- Price
- $0.00
- Market cap
- 50.01K
- Price
- $0.00
- Market cap
- 3.15K
- Price
- $0.00
- Market cap
- 657.75K
- Price
- $0.00
- Market cap
- 512.27K
- Price
- $0.01
- Market cap
- 388.70K
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.